Navigation Links
Enhanze in Medical News

Halozyme Therapeutics to Hold Pipeline Update Conference Call on August 8

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics Added to Nasdaq Biotech Index

...covering the family of human enzymes known as hyaluronidases. The company's enhanze Technology is a novel drug delivery platform designed to increase the absor...logical therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10...

Baxter Reports Strong Third Quarter Sales and Earnings

...wn as KIOVIG(TM) in Europe). For patients using GAMMAGARD LIQUID 10% - currently administered intravenously - subcutaneous administration with enhanze Technology may increase convenience and improve the dispersion of the therapy. -- A collaboration with DEKA Research & Development Corp. and HHD...
Enhanze in Medical Technology

Halozyme Therapeutics' Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society

- Co-Injection of rHuPH20 with Humira Estimated to Increase the Maximal Steady State Subcutaneous Bioavailability from 64% to 100% - SAN DIEGO, July 09, 2007 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. , a biopharmaceutical company developing and commercializing recombinant human enzymes...

Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme

...an enzymes known as hyaluronidases. The company's enhanze Technology is a novel drug delivery platform desig...ics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compo...unds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic comp...

Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target

...hase 1 pharmacokinetic clinical trial with a subcutaneous formulation using enhanze Technology of a biologic directed to a Roche exclusive target. This has tri...logical therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic product, GAMMAGARD LIQUID 10%...

Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics Presents Findings on Combinations of rHuPH20 Enzyme With Bisphosphonates at the American Association for Cancer Research Conference

... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...

Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference

... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...

Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously

... Phase I/II data showed that enhanze Technology(TM) enabled subcutaneous administrat... administered combination of GAMMAGARD LIQUID with enhanze Technology was 92 percent of the traditional, mont...ivotal Phase III trial using GAMMAGARD LIQUID with enhanze Technology pending discussions with regulatory aut...

Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex

... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...
Enhanze in Biological Technology

Halozyme Receives $5.5 Million Payment From Baxter

...s that affect the extracellular matrix. Halozyme's enhanze Technology is a novel drug delivery platform desi...e company has key partnerships with Roche to apply enhanze Technology to Roche's biological therapeutic compo... to 13 targets and with Baxter BioScience to apply enhanze Technology to Baxter's biological therapeutic comp...

Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients

...neous (SC) administration of GAMMAGARD LIQUID with enhanze Technology is an investigational study and when ap...gics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compo...unds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic comp...

Halozyme Therapeutics Reports 2008 Third Quarter Financial Results

...n and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic product, GAMMAGARD LIQUID 10%...

Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics Announces Conference Call on November 6 to Review Third Quarter Results

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics to Present at Upcoming Investor Conferences

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics to Host Research Day for Investors and Analysts

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics to Present at Upcoming Investor Conferences

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...

Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives

...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...
Other Tags
(Date:9/17/2014)... 17, 2014 Altec Products, Inc., a ... today their Gold Sponsorship of the 2014 Epicor Prophet ... annual conference will take place in Dallas, TX at ... and is organized and hosted by the Epicor Prophet ... comprised of members from more than 900 companies in ...
(Date:9/17/2014)... Experienced dress company, Discount-Dress.com, announces that its ... trendy black bridesmaid dresses. Furthermore, the company has recently ... outfits. Readers can view more about the ... is a famous brand of special occasion gowns and ... as revamped old editions, the supplier has set a ...
(Date:9/17/2014)... CA (PRWEB) September 17, 2014 In a ... San Diego, Dr. William Groff, an expert on the condition ... it. Pearly penile papules , or PPP, is a ... thirties, although other men may be affected as well. The ... the penis. , “While PPP is not a sexually ...
(Date:9/17/2014)... biofilms conjure up images of slippery stones in a ... "bad" biofilms around they even cause pesky dental ... problems a team at the Wyss Institute for ... a robust new platform for designer nanomaterials that could ... textiles, and more. , In short, they want ...
(Date:9/17/2014)... Colo. (PRWEB) September 17, 2014 In ... Sentinel University offers tips to health IT professionals for ... , A recent study by HIMSS shows demand for ... and a candidate’s skill set is the differentiating factor ... that of an IT professional that has clinical workflow ...
Breaking Medicine News(10 mins):Health News:Altec Joins the 2014 Epicor Prophet 21 World Wide User Group Conference as a Gold Sponsor 2Health News:Altec Joins the 2014 Epicor Prophet 21 World Wide User Group Conference as a Gold Sponsor 3Health News:Discount-Dress.com’s Top Designers Are Now Busy Making Its New Black Bridesmaid Dresses 2Health News:New Video Depicts Best Treatment for PPP 2Health News:New Video Depicts Best Treatment for PPP 3Health News:Recruiting bacteria to be technology innovation partners 2Health News:Recruiting bacteria to be technology innovation partners 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 4
(Date:9/16/2014)... tree species has its own bacterial identity. That,s the ... other institutions who studied the genetic fingerprints of bacteria ... island. , "This study demonstrates for the first time ... different ecological strategies possess very different microbial communities on ... former postdoctoral researcher in the UO,s Institute of Ecology ...
(Date:9/16/2014)... A complex web of interaction between viruses, bacteria, ... by a growing international collaboration between Matthew Sullivan, ... of Ecology and Evolutionary Biology and Steven Hallam ... Canada. , "Bacteria are drivers of nutrient ... said. "As the climate is changing, so are ...
(Date:9/16/2014)... extravagant, colorful tail feathers in courtship of a peahen. ... camera developed by an engineer at Washington University in ... choose their mates based on a similar display. , ... used a bioinspired polarization camera developed by Viktor Gruev, ... Washington University, to make the discovery. His camera has ...
Breaking Biology News(10 mins):Microbiome research shows each tree species has a unique bacterial identity 2New research decodes virus-host interactions in ocean dead zones 2New research decodes virus-host interactions in ocean dead zones 3Camera developed at WUSTL sheds light on mate choice of swordtail fish 2
Other Contents